$PBYI PUMA BIOTECHNOLOGY, INC. Insider Trading Week 21/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PUMA BIOTECHNOLOGY, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PUMA BIOTECHNOLOGY, INC. in week 21/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 78.35 | 330 | 25,857 | 4,450,968 | 4.5 M to 4.5 M (-0.01 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 77.66 | 111,823 | 8,684,610 | 4,451,298 | 4.6 M to 4.5 M (-2.45 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 76.72 | 187,847 | 14,410,795 | 4,563,121 | 4.8 M to 4.6 M (-3.95 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 79.70 | 75,036 | 5,980,564 | 4,750,968 | 4.8 M to 4.8 M (-1.55 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 78.25 | 7,248 | 567,121 | 4,826,004 | 4.8 M to 4.8 M (-0.15 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 77.61 | 232,190 | 18,021,404 | 4,833,252 | 5.1 M to 4.8 M (-4.58 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 76.91 | 85,526 | 6,577,471 | 5,065,442 | 5.2 M to 5.1 M (-1.66 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 75.00 | 116,133 | 8,709,975 | 5,150,968 | 5.3 M to 5.2 M (-2.20 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 74.49 | 48,865 | 3,639,817 | 5,267,101 | 5.3 M to 5.3 M (-0.92 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 73.29 | 175,687 | 12,875,837 | 5,315,966 | 5.5 M to 5.3 M (-3.20 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 72.22 | 52,300 | 3,776,933 | 5,491,653 | 5.5 M to 5.5 M (-0.94 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 70.31 | 53,600 | 3,768,493 | 5,543,953 | 5.6 M to 5.5 M (-0.96 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 69.00 | 39,115 | 2,698,935 | 5,597,553 | 5.6 M to 5.6 M (-0.69 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 68.13 | 50,000 | 3,406,455 | 5,636,668 | 5.7 M to 5.6 M (-0.88 %) |